about
Multiple sclerosis: molecular mechanisms and therapeutic opportunitiesUnraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.Treating multiple sclerosis with monoclonal antibodies: a 2013 update.Lipocalin 2 is present in the EAE brain and is modulated by natalizumabA peptide talk between JC virus and the human host: from silent infection to autoimmunity.Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treating multiple sclerosis with natalizumab.
@en
Treating multiple sclerosis with natalizumab.
@nl
type
label
Treating multiple sclerosis with natalizumab.
@en
Treating multiple sclerosis with natalizumab.
@nl
prefLabel
Treating multiple sclerosis with natalizumab.
@en
Treating multiple sclerosis with natalizumab.
@nl
P2093
P2860
P356
P1476
Treating multiple sclerosis with natalizumab.
@en
P2093
Guglielmo Lucchese
Maria Trojano
Pietro Iaffaldano
P2860
P304
P356
10.1586/ERN.11.154
P577
2011-12-01T00:00:00Z